DWQA Questions › Tag: clinical trial
Filter:AllOpenResolvedClosedUnanswered
The trial to assess chelation therapy 2 (TACT2) on cardiovascular outcomes in patients with diabetes and a prior myocardial infarction (MI) was reported in September, 2024. While there was a significant reduction in circulating heavy metals following months of weekly intravenous EDTA infusions, there was not a significant reduction in cardiovascular events or mortality. You told us previously that EDTA therapy was actually beneficial, as the first TACT study showed, but that the interlopers were suppressing beneficial clinical data. Is that the reason for the failed confirmation with the TACT2 follow-up?
ClosedNicola asked 3 weeks ago • 
60 views0 answers0 votes
A viewer asks: “Source Creator, Is it true that the dissolution of chlorine dioxide gas in water, as formulated by Jim Humble, obtained by mixing sodium chlorite with an organic acid, in the proportions indicated by him, can eliminate the malaria parasite in a single day, and is effective as an antibacterial and antifungal, without harming the cells of the body due to its low oxidation potential, and can dissolve tumors by apoptosis of cancer cells, and perhaps help against the spread of coronavirus by denaturing the virus capsids?”
ClosedNicola asked 5 years ago • 
755 views0 answers0 votes
Ask Question